FRIDAY, Jan. 14, 2022 (HealthDay News) — A three-month sexual abstinence rule for blood donations from sexually active gay and bisexual men should be dropped by the U.S. Food and Drug Administration, critics urge as the country struggles with a blood shortage. Right now, based on the slight chance ofContinue Reading

TUESDAY, Jan. 11, 2022 – (HealthDay News) — Men who are broken-hearted or just unlucky in love could be more likely to have health-damaging inflammation, new research suggests. Serious breakups and solo living for many years may increase the risk of ill health and death — but apparently only forContinue Reading

MONDAY, Jan. 3, 2022 (HealthDay News) — An international trial found that a once-a-day antiretroviral medication for kids with HIV is not only cheap and easy to take, but also better at suppressing HIV than standard treatments. “Our findings provide strong evidence for the global rollout of dolutegravir for childrenContinue Reading

THURSDAY, Dec. 9, 2021 (HealthDay News) — What do all the microbes living rent-free in your gut have to do with disease risk? Perhaps a lot. A groundbreaking analysis of decades-old stool and blood samples from the early AIDS epidemic suggests that men who had high levels of inflammation-causing bacteriaContinue Reading

THURSDAY, Dec. 3, 2021 (HealthDay News) — Racism is “a public health threat” that must be tackled to end the global HIV/AIDS epidemic, the Biden administration said Wednesday in announcing its new strategy to fight the disease. Over generations, “structural inequities have resulted in racial and ethnic health disparities thatContinue Reading

WEDNESDAY, Dec. 1, 2021 (HealthDay News) — With HIV a continuing threat to women’s health, the World Health Organization (WHO) has approved the first long-acting device to protect women from sexually transmitted HIV. The device is a vaginal ring made of silicone elastomer, a flexible rubber-like material that makes itContinue Reading

FRIDAY, Nov. 26, 2021 (HealthDay News) — Women getting vaccinated against the cancer-causing human papillomavirus (HPV) now need two or three shots, but an African clinical trial suggests a single dose is just as effective. The finding could speed up the immunization process in developing countries with high levels ofContinue Reading